Medical Care

Global Longevity and Anti-senescence Therapy Market Insights, Forecast to 2030

Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be reluctant to do it, is a natural part of life.Skin can appear as the lapse of years a variety of problems are like furrow, flabby, chromatic spot, dark dumb etc.Anti-aging is to help reduce the production of free radicals and increase skin elasticity by supplementing antioxidant substances, while supplementing collagen or enzyme, anti-aging dietary therapy and anti-aging skin care products can effectively delay aging.
Market Analysis and Insights: Global Longevity and Anti-senescence Therapy Market
The global Longevity and Anti-senescence Therapy market is projected to grow from US$ 355 million in 2024 to US$ 566.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period.
The US & Canada market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Longevity and Anti-senescence Therapy include Bristol Myers Squibb, CohBar, Life Biosciences, AgeX Therapeutics, Unity Biotechnology, Calico Life Sciences, Oisin Biotechnologies, T.A. Sciences and BioAge Labs, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Longevity and Anti-senescence Therapy is widely used in various fields, such as Hospital, Medical Service Institution and Others,, etc. Hospital provides greatest supports to the Longevity and Anti-senescence Therapy industry development. In 2023, global % revenue of Longevity and Anti-senescence Therapy went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Longevity and Anti-senescence Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Longevity and Anti-senescence Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Longevity and Anti-senescence Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Longevity and Anti-senescence Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Longevity and Anti-senescence Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Longevity and Anti-senescence Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bristol Myers Squibb
CohBar
Life Biosciences
AgeX Therapeutics
Unity Biotechnology
Calico Life Sciences
Oisin Biotechnologies
T.A. Sciences
BioAge Labs
Retro Biosciences
Senolytic Therapeutics
Segment by Type
Drug Therapy
Gene Therapy
Immunotherapy
Others
Segment by Application
Hospital
Medical Service Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Longevity and Anti-senescence Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Longevity and Anti-senescence Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Longevity and Anti-senescence Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Drug Therapy
1.2.3 Gene Therapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Service Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Longevity and Anti-senescence Therapy Market Perspective (2019-2030)
2.2 Global Longevity and Anti-senescence Therapy Growth Trends by Region
2.2.1 Longevity and Anti-senescence Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Longevity and Anti-senescence Therapy Historic Market Size by Region (2019-2024)
2.2.3 Longevity and Anti-senescence Therapy Forecasted Market Size by Region (2025-2030)
2.3 Longevity and Anti-senescence Therapy Market Dynamics
2.3.1 Longevity and Anti-senescence Therapy Industry Trends
2.3.2 Longevity and Anti-senescence Therapy Market Drivers
2.3.3 Longevity and Anti-senescence Therapy Market Challenges
2.3.4 Longevity and Anti-senescence Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Longevity and Anti-senescence Therapy by Players
3.1.1 Global Longevity and Anti-senescence Therapy Revenue by Players (2019-2024)
3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Longevity and Anti-senescence Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Longevity and Anti-senescence Therapy Market Concentration Ratio
3.4.1 Global Longevity and Anti-senescence Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Longevity and Anti-senescence Therapy Revenue in 2023
3.5 Global Key Players of Longevity and Anti-senescence Therapy Head office and Area Served
3.6 Global Key Players of Longevity and Anti-senescence Therapy, Product and Application
3.7 Global Key Players of Longevity and Anti-senescence Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Longevity and Anti-senescence Therapy Breakdown Data by Type
4.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Type (2019-2024)
4.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2025-2030)
5 Longevity and Anti-senescence Therapy Breakdown Data by Application
5.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Application (2019-2024)
5.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Longevity and Anti-senescence Therapy Market Size (2019-2030)
6.2 North America Longevity and Anti-senescence Therapy Market Size by Type
6.2.1 North America Longevity and Anti-senescence Therapy Market Size by Type (2019-2024)
6.2.2 North America Longevity and Anti-senescence Therapy Market Size by Type (2025-2030)
6.2.3 North America Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
6.3 North America Longevity and Anti-senescence Therapy Market Size by Application
6.3.1 North America Longevity and Anti-senescence Therapy Market Size by Application (2019-2024)
6.3.2 North America Longevity and Anti-senescence Therapy Market Size by Application (2025-2030)
6.3.3 North America Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
6.4 North America Longevity and Anti-senescence Therapy Market Size by Country
6.4.1 North America Longevity and Anti-senescence Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
6.4.3 North America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Longevity and Anti-senescence Therapy Market Size (2019-2030)
7.2 Europe Longevity and Anti-senescence Therapy Market Size by Type
7.2.1 Europe Longevity and Anti-senescence Therapy Market Size by Type (2019-2024)
7.2.2 Europe Longevity and Anti-senescence Therapy Market Size by Type (2025-2030)
7.2.3 Europe Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Application
7.3.1 Europe Longevity and Anti-senescence Therapy Market Size by Application (2019-2024)
7.3.2 Europe Longevity and Anti-senescence Therapy Market Size by Application (2025-2030)
7.3.3 Europe Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
7.4 Europe Longevity and Anti-senescence Therapy Market Size by Country
7.4.1 Europe Longevity and Anti-senescence Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
7.4.3 Europe Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Longevity and Anti-senescence Therapy Market Size (2019-2030)
8.2 China Longevity and Anti-senescence Therapy Market Size by Type
8.2.1 China Longevity and Anti-senescence Therapy Market Size by Type (2019-2024)
8.2.2 China Longevity and Anti-senescence Therapy Market Size by Type (2025-2030)
8.2.3 China Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
8.3 China Longevity and Anti-senescence Therapy Market Size by Application
8.3.1 China Longevity and Anti-senescence Therapy Market Size by Application (2019-2024)
8.3.2 China Longevity and Anti-senescence Therapy Market Size by Application (2025-2030)
8.3.3 China Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Longevity and Anti-senescence Therapy Market Size (2019-2030)
9.2 Asia Longevity and Anti-senescence Therapy Market Size by Type
9.2.1 Asia Longevity and Anti-senescence Therapy Market Size by Type (2019-2024)
9.2.2 Asia Longevity and Anti-senescence Therapy Market Size by Type (2025-2030)
9.2.3 Asia Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
9.3 Asia Longevity and Anti-senescence Therapy Market Size by Application
9.3.1 Asia Longevity and Anti-senescence Therapy Market Size by Application (2019-2024)
9.3.2 Asia Longevity and Anti-senescence Therapy Market Size by Application (2025-2030)
9.3.3 Asia Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
9.4 Asia Longevity and Anti-senescence Therapy Market Size by Region
9.4.1 Asia Longevity and Anti-senescence Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Longevity and Anti-senescence Therapy Market Size by Region (2019-2024)
9.4.3 Asia Longevity and Anti-senescence Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Longevity and Anti-senescence Therapy Introduction
11.1.4 Bristol Myers Squibb Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.1.5 Bristol Myers Squibb Recent Developments
11.2 CohBar
11.2.1 CohBar Company Details
11.2.2 CohBar Business Overview
11.2.3 CohBar Longevity and Anti-senescence Therapy Introduction
11.2.4 CohBar Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.2.5 CohBar Recent Developments
11.3 Life Biosciences
11.3.1 Life Biosciences Company Details
11.3.2 Life Biosciences Business Overview
11.3.3 Life Biosciences Longevity and Anti-senescence Therapy Introduction
11.3.4 Life Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.3.5 Life Biosciences Recent Developments
11.4 AgeX Therapeutics
11.4.1 AgeX Therapeutics Company Details
11.4.2 AgeX Therapeutics Business Overview
11.4.3 AgeX Therapeutics Longevity and Anti-senescence Therapy Introduction
11.4.4 AgeX Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.4.5 AgeX Therapeutics Recent Developments
11.5 Unity Biotechnology
11.5.1 Unity Biotechnology Company Details
11.5.2 Unity Biotechnology Business Overview
11.5.3 Unity Biotechnology Longevity and Anti-senescence Therapy Introduction
11.5.4 Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.5.5 Unity Biotechnology Recent Developments
11.6 Calico Life Sciences
11.6.1 Calico Life Sciences Company Details
11.6.2 Calico Life Sciences Business Overview
11.6.3 Calico Life Sciences Longevity and Anti-senescence Therapy Introduction
11.6.4 Calico Life Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.6.5 Calico Life Sciences Recent Developments
11.7 Oisin Biotechnologies
11.7.1 Oisin Biotechnologies Company Details
11.7.2 Oisin Biotechnologies Business Overview
11.7.3 Oisin Biotechnologies Longevity and Anti-senescence Therapy Introduction
11.7.4 Oisin Biotechnologies Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.7.5 Oisin Biotechnologies Recent Developments
11.8 T.A. Sciences
11.8.1 T.A. Sciences Company Details
11.8.2 T.A. Sciences Business Overview
11.8.3 T.A. Sciences Longevity and Anti-senescence Therapy Introduction
11.8.4 T.A. Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.8.5 T.A. Sciences Recent Developments
11.9 BioAge Labs
11.9.1 BioAge Labs Company Details
11.9.2 BioAge Labs Business Overview
11.9.3 BioAge Labs Longevity and Anti-senescence Therapy Introduction
11.9.4 BioAge Labs Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.9.5 BioAge Labs Recent Developments
11.10 Retro Biosciences
11.10.1 Retro Biosciences Company Details
11.10.2 Retro Biosciences Business Overview
11.10.3 Retro Biosciences Longevity and Anti-senescence Therapy Introduction
11.10.4 Retro Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.10.5 Retro Biosciences Recent Developments
11.11 Senolytic Therapeutics
11.11.1 Senolytic Therapeutics Company Details
11.11.2 Senolytic Therapeutics Business Overview
11.11.3 Senolytic Therapeutics Longevity and Anti-senescence Therapy Introduction
11.11.4 Senolytic Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.11.5 Senolytic Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Others
Table 6. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Longevity and Anti-senescence Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Longevity and Anti-senescence Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Longevity and Anti-senescence Therapy Market Share by Region (2019-2024)
Table 10. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Longevity and Anti-senescence Therapy Market Share by Region (2025-2030)
Table 12. Longevity and Anti-senescence Therapy Market Trends
Table 13. Longevity and Anti-senescence Therapy Market Drivers
Table 14. Longevity and Anti-senescence Therapy Market Challenges
Table 15. Longevity and Anti-senescence Therapy Market Restraints
Table 16. Global Longevity and Anti-senescence Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Longevity and Anti-senescence Therapy Revenue Share by Players (2019-2024)
Table 18. Global Top Longevity and Anti-senescence Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longevity and Anti-senescence Therapy as of 2023)
Table 19. Global Longevity and Anti-senescence Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Longevity and Anti-senescence Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Longevity and Anti-senescence Therapy, Headquarters and Area Served
Table 22. Global Key Players of Longevity and Anti-senescence Therapy, Product and Application
Table 23. Global Key Players of Longevity and Anti-senescence Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Longevity and Anti-senescence Therapy Revenue Share by Application (2019-2024)
Table 31. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Longevity and Anti-senescence Therapy Revenue Share by Application (2025-2030)
Table 33. North America Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Longevity and Anti-senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Longevity and Anti-senescence Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Longevity and Anti-senescence Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 65. Bristol Myers Squibb Company Details
Table 66. Bristol Myers Squibb Business Overview
Table 67. Bristol Myers Squibb Longevity and Anti-senescence Therapy Product
Table 68. Bristol Myers Squibb Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 69. Bristol Myers Squibb Recent Developments
Table 70. CohBar Company Details
Table 71. CohBar Business Overview
Table 72. CohBar Longevity and Anti-senescence Therapy Product
Table 73. CohBar Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 74. CohBar Recent Developments
Table 75. Life Biosciences Company Details
Table 76. Life Biosciences Business Overview
Table 77. Life Biosciences Longevity and Anti-senescence Therapy Product
Table 78. Life Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 79. Life Biosciences Recent Developments
Table 80. AgeX Therapeutics Company Details
Table 81. AgeX Therapeutics Business Overview
Table 82. AgeX Therapeutics Longevity and Anti-senescence Therapy Product
Table 83. AgeX Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 84. AgeX Therapeutics Recent Developments
Table 85. Unity Biotechnology Company Details
Table 86. Unity Biotechnology Business Overview
Table 87. Unity Biotechnology Longevity and Anti-senescence Therapy Product
Table 88. Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 89. Unity Biotechnology Recent Developments
Table 90. Calico Life Sciences Company Details
Table 91. Calico Life Sciences Business Overview
Table 92. Calico Life Sciences Longevity and Anti-senescence Therapy Product
Table 93. Calico Life Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 94. Calico Life Sciences Recent Developments
Table 95. Oisin Biotechnologies Company Details
Table 96. Oisin Biotechnologies Business Overview
Table 97. Oisin Biotechnologies Longevity and Anti-senescence Therapy Product
Table 98. Oisin Biotechnologies Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 99. Oisin Biotechnologies Recent Developments
Table 100. T.A. Sciences Company Details
Table 101. T.A. Sciences Business Overview
Table 102. T.A. Sciences Longevity and Anti-senescence Therapy Product
Table 103. T.A. Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 104. T.A. Sciences Recent Developments
Table 105. BioAge Labs Company Details
Table 106. BioAge Labs Business Overview
Table 107. BioAge Labs Longevity and Anti-senescence Therapy Product
Table 108. BioAge Labs Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 109. BioAge Labs Recent Developments
Table 110. Retro Biosciences Company Details
Table 111. Retro Biosciences Business Overview
Table 112. Retro Biosciences Longevity and Anti-senescence Therapy Product
Table 113. Retro Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 114. Retro Biosciences Recent Developments
Table 115. Senolytic Therapeutics Company Details
Table 116. Senolytic Therapeutics Business Overview
Table 117. Senolytic Therapeutics Longevity and Anti-senescence Therapy Product
Table 118. Senolytic Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 119. Senolytic Therapeutics Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Longevity and Anti-senescence Therapy Market Share by Type: 2023 VS 2030
Figure 3. Drug Therapy Features
Figure 4. Gene Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Others Features
Figure 7. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Longevity and Anti-senescence Therapy Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Medical Service Institution Case Studies
Figure 11. Others Case Studies
Figure 12. Longevity and Anti-senescence Therapy Report Years Considered
Figure 13. Global Longevity and Anti-senescence Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Longevity and Anti-senescence Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Longevity and Anti-senescence Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Longevity and Anti-senescence Therapy Market Share by Players in 2023
Figure 17. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longevity and Anti-senescence Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Longevity and Anti-senescence Therapy Revenue in 2023
Figure 19. North America Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 21. North America Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 22. North America Longevity and Anti-senescence Therapy Market Share by Country (2019-2030)
Figure 23. United States Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 27. Europe Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 28. Europe Longevity and Anti-senescence Therapy Market Share by Country (2019-2030)
Figure 29. Germany Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 37. China Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 38. Asia Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 40. Asia Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 41. Asia Longevity and Anti-senescence Therapy Market Share by Region (2019-2030)
Figure 42. Japan Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Country (2019-2030)
Figure 52. Brazil Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 59. CohBar Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 60. Life Biosciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 61. AgeX Therapeutics Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 62. Unity Biotechnology Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 63. Calico Life Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 64. Oisin Biotechnologies Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 65. T.A. Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 66. BioAge Labs Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 67. Retro Biosciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 68. Senolytic Therapeutics Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies